Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients

It was previously reported that the gain-of-function -28 guanine allele of the promoter single nucleotide polymorphism (SNP; cytosine to guanine substitution of nucleotide -28 (-28C>G)) in the CC chemokine ligand 5 gene (CCL5) was associated with susceptibility to late-onset asthma in patients who developed asthma at age ≥40 yrs. The clinical diagnosis of chronic obstructive pulmonary disease (COPD) includes emphysema and small airway disease, and upregulation of CCL5 has been described in the airways of patients with COPD. It was hypothesised that CCL5 has a genetic impact upon the variable expression of emphysema in patients with COPD. Patients with COPD were studied (n = 267). All of the patients underwent pulmonary high-resolution computed tomography (CT), and visual scoring (CT score) was performed to determine emphysema severity. Three SNPs of CCL5 were genotyped, including -403G>A, -28C>G and 375T>C. A significant difference was found in CT score according to CCL5 genotype; the -28G allele was inversely associated with CT score. When the analysis was confined to 180 patients with bronchial reversibility of <15%, even stronger evidence for this association was noted. Functional single nucleotide polymorphisms in the CC chemokine ligand 5 gene were associated with milder emphysema. Together with previous findings, the present study may identify the CC chemokine ligand 5 gene as part of a common pathway in the pathogenesis of late-onset asthma and chronic obstructive pulmonary disease with milder emphysema.

[1]  M. Hasegawa,et al.  Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease , 2007, Thorax.

[2]  M. Hasegawa,et al.  Characterization of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease , 2007 .

[3]  S. Holgate Rhinoviruses in the pathogenesis of asthma: the bronchial epithelium as a major disease target. , 2006, The Journal of allergy and clinical immunology.

[4]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[5]  J. Wedzicha,et al.  Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[6]  A. Zhernakova,et al.  Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes , 2006, Genes and Immunity.

[7]  N. Kajiwara,et al.  CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection , 2005, Nature Medicine.

[8]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[9]  R. Djukanović,et al.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD , 2004, Thorax.

[10]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[11]  C. Jang,et al.  Chemokine RANTES Promoter Polymorphisms in Allergic Rhinitis , 2004, The Laryngoscope.

[12]  J. Wedzicha Role of viruses in exacerbations of chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[13]  D. Kwiatkowski,et al.  Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. , 2003, The Journal of infectious diseases.

[14]  L. See,et al.  The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. , 2003, The Journal of allergy and clinical immunology.

[15]  W. Busse,et al.  Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. , 2003, American journal of respiratory cell and molecular biology.

[16]  M. Nishimura,et al.  A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. , 2002, American journal of respiratory and critical care medicine.

[17]  Jeffrey D. Morton,et al.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. , 2002, The Journal of clinical investigation.

[18]  J. Goedert,et al.  Modulating influence on HIV/AIDS by interacting RANTES gene variants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Noah,et al.  Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. , 2002, Clinical immunology.

[20]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[21]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[22]  T. Seemungal,et al.  Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[23]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[24]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[25]  U. Wahn,et al.  Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES1 , 2000, The Journal of Immunology.

[26]  K Fukutake,et al.  Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Adachi,et al.  Expression of RANTES by normal airway epithelial cells after influenza virus A infection. , 1998, American journal of respiratory cell and molecular biology.

[28]  R. Garofalo,et al.  Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. , 1997, The Journal of infectious diseases.

[29]  G. Laszlo,et al.  Computed tomography in pulmonary emphysema. , 1982, Clinical radiology.